ARCHIVES

Conversation with The Cancer Letter: Statistician Lori Dodd Saw Research Question In the Midst of 2007 ODAC Debate Over Avastin

This article is from The Cancer Letter archive.

Vol. 38 No. 30 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

June 28, 2013

NIH grant success rate drops to under 20 percent after 2011 budget cuts

May 13, 2011

In Brief: NIH Appeals Board Restores Nassau CCOP Funding, PI Says It Is Now Meeting Patient Accrual Goal

February 22, 1985

Caterpillar In. Benefits Plan To Cover Entry On BMT trials

June 14, 1996

FCRF Program Proving Good Basic Research Can Be Supported By NCI With a Contract

January 23, 1987

Q&A: Data that Killed CYP2D6 Testing Contradict Fundamental Law of Nature

May 18, 2012